Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 2/20 | 0.47 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.47 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.47 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | MMP1 | P03956 | 1/20 | 0.45 |
| ▸ | MMP2 | P08253 | 1/20 | 0.45 |
| ▸ | MMP9 | P14780 | 1/20 | 0.45 |
| ▸ | MMP8 | P22894 | 1/20 | 0.45 |
| ▸ | MMP13 | P45452 | 1/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL777482 | 0.87 | PKM (0.46) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL29041060 | 0.83 | F2 (0.42) | F2PRSS1PRSS2PRSS3MEN1 | |
| SCHEMBL197570 | 0.80 | CA12 (0.46) | MEN1KMT2ACA1CA2ALDH1A1 | |
| SCHEMBL28944799 | 0.80 | MEN1 (0.50) | F2PRSS1PRSS2PRSS3MEN1 | |
| SCHEMBL16467640 | 0.80 | CYP1A2 (0.42) | F2PRSS1PRSS2PRSS3MEN1 | |
| SCHEMBL16467726 | 0.78 | CYP1A2 (0.41) | F2PRSS1PRSS2PRSS3MEN1 | |
| SCHEMBL27524 | 0.78 | GAA (0.56) | F2PRSS1PRSS2PRSS3MEN1 | |
| SCHEMBL9901122 | 0.78 | GAA (0.56) | F2PRSS1PRSS2PRSS3MEN1 | |
| SCHEMBL14779504 | 0.77 | CA1 (0.46) | F2PRSS1PRSS2PRSS3MEN1 | |
| Methanesulfonic Acid Methyl Ester SCHEMBL27792596 | 0.77 | USP2 (0.56) | F2PRSS1PRSS2PRSS3SOS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110635167-B | Nonaqueous electrolyte solution, battery containing same, and electric vehicle | 比亚迪股份有限公司 | 2021-04-20 | — | — | CN | claimed |
| CN-110635167-A | Nonaqueous electrolyte solution, battery containing same, and electric vehicle | 比亚迪股份有限公司 | 2019-12-31 | — | — | CN | claimed |
| US-6737550-B2 | LITHIUM SALT OF 4- FLUOROPHENYL METHYL SULFONE AS THE CHEMICAL INTERMEDIATE; DRUG WITH ANTIANDROGEN ACTIVITY | BIOGAL GRYOGYSZERGYAR RT. (HU) | 2004-05-18 | — | — | US | claimed |
| EP-3276735-B1 | NONAQUEOUS ELECTROLYTE FOR SODIUM SECONDARY BATTERY AND SODIUM SECONDARY BATTERY | SUMITOMO CHEMICAL CO (JP) | 2023-07-12 | — | — | EP | disclosed |
| CN-109071541-B | Phenyl [ a ] indole [2,3-g ] quinolizine compound, preparation method thereof, pharmaceutical composition and application thereof | 中国科学院上海药物研究所 | 2021-06-18 | — | — | CN | disclosed |
| CN-110635167-B | Nonaqueous electrolyte solution, battery containing same, and electric vehicle | 比亚迪股份有限公司 | 2021-04-20 | — | — | CN | disclosed |
| CN-107431246-B | Nonaqueous electrolyte for sodium secondary battery and sodium secondary battery | 住友化学株式会社 | 2021-03-09 | — | — | CN | disclosed |
| WO-2020237169-A1 | SEMI-SYNTHETIC ANALOGUES OF EPIPOLYTHIODIOXOPIPERAZINE ALKALOIDS | OHIO STATE INNOVATION FOUNDATION (US) | 2020-11-26 | — | — | WO | disclosed |
| EP-2841429-B1 | TETRAZOLINONE COMPOUNDS AND ITS USE AS PESTICIDES | SUMITOMO CHEMICAL CO (JP) | 2020-10-21 | — | — | EP | disclosed |
| CN-110635167-A | Nonaqueous electrolyte solution, battery containing same, and electric vehicle | 比亚迪股份有限公司 | 2019-12-31 | — | — | CN | disclosed |
| EP-2827433-B1 | SECONDARY BATTERY ELECTROLYTE AND SECONDARY BATTERY USING SAME | ENVISION AESC ENERGY DEVICES LTD (JP) | 2019-09-25 | — | — | EP | disclosed |
| US-20070196421-A1 | Soft tissue implants and drug combination compositions, and use thereof | ANGIOTECH INTERNATIONAL AG (CH) | 2007-08-23 | — | — | US | disclosed |
| US-20070196421-A1 | Soft tissue implants and drug combination compositions, and use thereof | ANGIOTECH INTERNATIONAL AG (CH) | 2007-08-23 | — | — | US | disclosed |
| US-20070198063-A1 | Electrical devices and anti-scarring drug combinations | HUNTER WILLIAM L | 2007-08-23 | — | — | US | disclosed |
| US-20070198063-A1 | Electrical devices and anti-scarring drug combinations | HUNTER WILLIAM L | 2007-08-23 | — | — | US | disclosed |
| WO-2007041677-A9 | SOFT TISSUE IMPLANTS AND DRUG COMBINATION COMPOSITIONS, AND USE THEREOF | COMBINATORX INC (US) | 2007-05-31 | — | — | WO | disclosed |
| WO-2007041584-A2 | IMPLANTABLE SENSORS, IMPLANTABLE PUMPS, AND ANTI-SCARRING DRUG COMBINATIONS | COMBINATORX, INCORPORATED (US) | 2007-04-12 | — | — | WO | disclosed |
| WO-2007041463-A2 | ELECTRICAL DEVICES AND ANTI-SCARRING DRUG COMBINATIONS | COMBINATORX, INCORPORATED (US) | 2007-04-12 | — | — | WO | disclosed |
| WO-2007041677-A2 | SOFT TISSUE IMPLANTS AND DRUG COMBINATION COMPOSITIONS, AND USE THEREOF | COMBINATORX, INCORPORATED (US) | 2007-04-12 | — | — | WO | disclosed |
| WO-2007041593-A2 | ANTI-SCARRING DRUG COMBINATIONS AND USE THEREOF | COMBINATORX, INCORPORATED (US) | 2007-04-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070196421-A1 | Soft tissue implants and drug combination compositions, and use thereof | COL2A1, MMP1, FN1 | F2 2448/4885PRSS1 346/4885PRSS2 682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.